To ask the Secretary of State for Health and Social Care, if he will allow contacts of people with immunosuppression to be eligible for the covid-19 vaccination programme in autumn 2024.

To ask the Secretary of State for Health and Social Care, whether he plans to provide covid-19 vaccinations to the (a) families and (b) carers of patients with immunosuppressant diseases.

To ask the Secretary of State for Health and Social Care, if he will include (a) unpaid family carers and (b) household contacts of immuno-suppressed individuals in the covid-19 vaccination programme.

To ask the Secretary of State for Health and Social Care, if he will make it his policy to extend the covid-19 booster vaccination this autumn to (a) unpaid and (b) young carers.

The primary aim of the autumn 2024 COVID-19 vaccination programme remains the prevention of severe illness, hospitalisations, and deaths, arising from COVID-19. On 2 August 2024 the Government accepted the advice of the independent Joint Committee on Vaccination and Immunisation (JCVI) to offer a COVID-19 vaccination to those aged 65 years old or over, those living in care homes for older adults, and those aged between six months and 64 years old who are in a clinical risk group in England this autumn. Additionally, vaccination will be offered to all frontline health and social care workers, as well as staff in care homes for older adults.

There are no plans to offer a COVID-19 vaccination to unpaid carers, including young carers, or the families and household contacts of people with immunosuppression, during the autumn 2024 campaign in England. Unpaid carers and household contacts of those with immunosuppression have previously been offered vaccination on the basis that it indirectly protected those more vulnerable with whom they are in contact. The JCVI advice for autumn 2024 is that in the era of highly transmissible Omicron sub-variants, any protection offered by the vaccines against transmission of infection from one person to another is expected to be extremely limited. The indirect benefits of vaccination in these groups, vaccinating an individual to reduce the risk of severe disease in other people, are therefore less evident than in previous years.